These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35386961)

  • 1. Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA.
    Claeys N; Teeling MT; Legrand P; Poppe M; Verschueren P; De Prins L; Cools L; Cypers L; Fokkens WJ; Hopkins C; Hellings PW
    Front Allergy; 2021; 2():761388. PubMed ID: 35386961
    [No Abstract]   [Full Text] [Related]  

  • 2. White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA.
    De Prins L; Raap U; Mueller T; Schmid-Grendelmeier P; Haase CH; Backer V; Fokkens W; Benoist LB; Prokopakis E; Hopkins C; Claeys N; Teeling T; Cypers L; Cools L; Bjermer LH; Diamant Z; Wahn U; Scadding G; Bachert C; Patel SR; Van Staeyen E; Hellings P
    Front Allergy; 2022; 3():889221. PubMed ID: 35769567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
    Hellings PW; Alobid I; Anselmo-Lima WT; Bernal-Sprekelsen M; Bjermer L; Caulley L; Chaker A; Constantinidis J; Conti DM; De Corso E; Desrosiers M; Diamant Z; Gevaert P; Han JK; Heffler E; Hopkins C; Landis BN; Lourenco O; Lund V; Luong AU; Mullol J; Peters A; Philpott C; Reitsma S; Ryan D; Scadding G; Senior B; Tomazic PV; Toskala E; Van Zele T; Viskens AS; Wagenmann M; Fokkens WJ
    Allergy; 2024 May; 79(5):1123-1133. PubMed ID: 38108602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA.
    Teeling T; Djouder C; Laurens H; Preyra JH; Shire CME; Van Staeyen E; Conti DM; Scadding GK; Hellings PW
    Front Allergy; 2024; 5():1372919. PubMed ID: 38596453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.
    Bachert C; Han JK; Wagenmann M; Hosemann W; Lee SE; Backer V; Mullol J; Gevaert P; Klimek L; Prokopakis E; Knill A; Cavaliere C; Hopkins C; Hellings P
    J Allergy Clin Immunol; 2021 Jan; 147(1):29-36. PubMed ID: 33227318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA.
    Claeys N; Teeling MT; Legrand P; Poppe M; Verschueren P; De Prins L; Cools L; Cypers L; Fokkens WJ; Hopkins C; Hellings PW
    Front Allergy; 2021; 2():789425. PubMed ID: 35389606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUFOREA summit in Brussels 2023:
    Hellings PW; Lau S; Scadding GK; Bjermer L; Backer V; Chaker AM; Conti DM; De Corso E; Diamant Z; Djukanovic R; Fokkens W; Gevaert P; Gray CL; Han JK; Heaney LG; Hoffmann HJ; Jesenak M; Johansen P; Kumaran MS; McDonald M; Melén E; Mullol J; Reitsma S; Ryan D; Scadding G; Schmid-Grendelmeier P; Teeling T; Odemyr M; Wahn U
    Front Allergy; 2023; 4():1236977. PubMed ID: 37577332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
    Fokkens WJ; De Corso E; Backer V; Bernal-Sprekelsen M; Bjermer L; von Buchwald C; Chaker A; Diamant Z; Gevaert P; Han J; Hopkins C; Hox V; Klimek L; Lund VJ; Lee S; Luong A; Mullol J; Peters A; Pfaar O; Reitsma S; Toppila-Salmi S; Scadding GK; Sedaghat AR; Viskens AS; Wagenmann M; Hellings PW
    Rhinology; 2024 Jun; 62(3):287-298. PubMed ID: 38217529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps.
    Ramkumar SP; Lal D; Miglani A
    Front Allergy; 2023; 4():1137907. PubMed ID: 36970067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUFOREA consensus on biologics for CRSwNP with or without asthma.
    Fokkens WJ; Lund V; Bachert C; Mullol J; Bjermer L; Bousquet J; Canonica GW; Deneyer L; Desrosiers M; Diamant Z; Han J; Heffler E; Hopkins C; Jankowski R; Joos G; Knill A; Lee J; Lee SE; Mariën G; Pugin B; Senior B; Seys SF; Hellings PW
    Allergy; 2019 Dec; 74(12):2312-2319. PubMed ID: 31090937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps.
    Bachert C; Bhattacharyya N; Desrosiers M; Khan AH
    J Asthma Allergy; 2021; 14():127-134. PubMed ID: 33603409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps.
    Cavaliere C; Incorvaia C; Frati F; Messineo D; Ciotti M; Greco A; de Vincentiis M; Masieri S
    Clin Mol Allergy; 2019; 17():3. PubMed ID: 30804712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach.
    Seccia V; D'Amato M; Scioscia G; Bagnasco D; Di Marco F; Fadda G; Menzella F; Pasquini E; Pelaia G; Tremante E; De Corso E; Bonini M
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Garcia D; Rosta E
    Curr Med Res Opin; 2020 Nov; 36(11):1913-1926. PubMed ID: 32851882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Rhinosinusitis Patients With and Without Polyps Experience Different Symptom Perception and Quality of Life Burdens.
    Talat R; Speth MM; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Am J Rhinol Allergy; 2020 Nov; 34(6):742-750. PubMed ID: 32437223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Allergy and Eosinophils on the Morbidity of Chronic Rhinosinusitis with Nasal Polyps in Northwest China.
    Chen F; Wen L; Qiao L; Shi Z; Xue T; Chen X; Li X
    Int Arch Allergy Immunol; 2019; 179(3):209-214. PubMed ID: 30970360
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.